These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 39375585

  • 21. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.
    Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, Den Boon S, Borroto Gutierrez SM, Bruchfeld J, Burhan E, Cavalcante S, Cedillos R, Chaisson R, Chee CB, Chesire L, Corbett E, Dara M, Denholm J, de Vries G, Falzon D, Ford N, Gale-Rowe M, Gilpin C, Girardi E, Go UY, Govindasamy D, D Grant A, Grzemska M, Harris R, Horsburgh CR, Ismayilov A, Jaramillo E, Kik S, Kranzer K, Lienhardt C, LoBue P, Lönnroth K, Marks G, Menzies D, Migliori GB, Mosca D, Mukadi YD, Mwinga A, Nelson L, Nishikiori N, Oordt-Speets A, Rangaka MX, Reis A, Rotz L, Sandgren A, Sañé Schepisi M, Schünemann HJ, Sharma SK, Sotgiu G, Stagg HR, Sterling TR, Tayeb T, Uplekar M, van der Werf MJ, Vandevelde W, van Kessel F, van't Hoog A, Varma JK, Vezhnina N, Voniatis C, Vonk Noordegraaf-Schouten M, Weil D, Weyer K, Wilkinson RJ, Yoshiyama T, Zellweger JP, Raviglione M.
    Eur Respir J; 2015 Dec; 46(6):1563-76. PubMed ID: 26405286
    [Abstract] [Full Text] [Related]

  • 22. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
    Sato S, Nagai H.
    Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data.
    Stockbridge EL, Loethen AD, Annan E, Miller TL.
    PLoS One; 2020 Feb; 15(12):e0243102. PubMed ID: 33270737
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective.
    Kowada A.
    J Infect; 2019 Jan; 78(1):58-65. PubMed ID: 30009853
    [Abstract] [Full Text] [Related]

  • 29. Incidence of Tuberculosis Among Immigrants in Korea Who Participated in a Latent Tuberculosis Infection Screening Program.
    Lee YJ, Min J, Myong JP, Lee YH, Park YJ, Kim Y, Kim G, Park G, Lee SS, Park JS, Kim JS, Kim HW.
    J Korean Med Sci; 2024 Jul 22; 39(28):e207. PubMed ID: 39048302
    [Abstract] [Full Text] [Related]

  • 30. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
    Tang J, Huang Y, Jiang S, Huang F, Ma T, Qi Y, Ma Y.
    Tuberculosis (Edinb); 2020 Sep 22; 124():101966. PubMed ID: 32866942
    [Abstract] [Full Text] [Related]

  • 31. Risk Groups of Developing Active Tuberculosis in Liver Transplant Recipients in a Tuberculosis Endemic Area: Risk Stratification by Chest Image and Interferon Gamma Release Assay.
    Kim SH, Oh S, Nham E, Ko JH, Huh K, Cho SY, Kang CI, Chung DR, Choi GS, Kim JM, Joh JW, Peck KR.
    Int J Infect Dis; 2021 Dec 22; 113():359-366. PubMed ID: 34718154
    [Abstract] [Full Text] [Related]

  • 32. Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults.
    Sultan B, Benn P, Mahungu T, Young M, Mercey D, Morris-Jones S, Miller RF.
    Int J STD AIDS; 2013 Oct 22; 24(10):775-9. PubMed ID: 23970606
    [Abstract] [Full Text] [Related]

  • 33. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I, Lalvani A, Southern J, Sitch A, Jackson C, Onyimadu O, Lipman M, Deeks JJ, Griffiths C, Bothamley G, Kon OM, Hayward A, Lord J, Drobniewski F.
    Health Technol Assess; 2018 Oct 22; 22(56):1-96. PubMed ID: 30334521
    [Abstract] [Full Text] [Related]

  • 34. Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation.
    Hadaya K, Bridevaux PO, Roux-Lombard P, Delort A, Saudan P, Martin PY, Janssens JP.
    Transplantation; 2013 Jun 27; 95(12):1485-90. PubMed ID: 23694948
    [Abstract] [Full Text] [Related]

  • 35. Serial interferon-γ release assay in children with latent tuberculosis infection and children with tuberculosis.
    Nenadić N, Kirin BK, Letoja IZ, Plavec D, Topić RZ, Dodig S.
    Pediatr Pulmonol; 2012 Apr 27; 47(4):401-8. PubMed ID: 21901862
    [Abstract] [Full Text] [Related]

  • 36. IGRA-based INH regimen for prevention of active tuberculosis after kidney transplantation: A single-centre retrospective study.
    Zeng J, Zhu D, Zhang H, Lin T, Song T.
    Int J Antimicrob Agents; 2024 Mar 27; 63(3):107093. PubMed ID: 38244813
    [Abstract] [Full Text] [Related]

  • 37. Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection.
    Lee EH, Kang YA, Leem AY, Park MS, Kim YS, Kim SK, Chang J, Kim SY.
    Sci Rep; 2017 Jul 25; 7(1):6473. PubMed ID: 28743918
    [Abstract] [Full Text] [Related]

  • 38. Combined IFN-γ and TNF-α release assay for differentiating active tuberculosis from latent tuberculosis infection.
    Kim JY, Park JH, Kim MC, Cha HH, Jeon NY, Park SY, Kim MJ, Chong YP, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH.
    J Infect; 2018 Oct 25; 77(4):314-320. PubMed ID: 29746954
    [Abstract] [Full Text] [Related]

  • 39. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil.
    Costa AG, Carvalho BKS, Araújo-Pereira M, Ibiapina HNS, Spener-Gomes R, Souza AB, Gomes-Silva A, Andrade AMS, Silva EC, Arriaga MB, Benjamin A, Rocha MS, Moreira ASR, Oliveira JG, Figueiredo MC, Turner MM, Durovni B, Cavalcante S, Kritski AL, Rolla VC, Sterling TR, Andrade BB, Cordeiro-Santos M, RePORT-Brazil Consortium.
    Microbiol Spectr; 2021 Dec 22; 9(3):e0116321. PubMed ID: 34851140
    [Abstract] [Full Text] [Related]

  • 40. Comparison of interferon-γ release assays, QuantiFERON TB-GIT and T-Spot.TB, in renal transplantation.
    Ishikawa S, Igari H, Akutsu N, Tsuyuzaki M, Aoyama H, Hasegawa M, Otsuki K, Maruyama M, Saigo K, Suzuki K, Yamagishi F.
    J Infect Chemother; 2017 Jul 22; 23(7):468-473. PubMed ID: 28438462
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.